Literature DB >> 1654210

Increased intracellular calcium is associated with progression of HPV-18 immortalized human keratinocytes to tumorigenicity.

L R Garrett1, D M Coder, J K McDougall.   

Abstract

Studies were conducted using normal and human papillomavirus Type 18 (HPV-18) immortalized human keratinocytes to assess possible alterations in the differentiation process as a consequence of increased intracellular calcium concentration. Normal keratinocytes exposed to increased extracellular calcium or the phorbol ester TPA, exhibited terminal differentiation characteristics. However, late passage HPV-18 immortalized keratinocytes (designated FEP-1811) were resistant to such terminal differentiation signals. Flow cytometric analyses of 1811 cells at various stages of passage in culture revealed progressively higher levels of intracellular calcium in the immortalized cells with passage in culture when compared to normal, primary keratinocytes. Furthermore, 1811 cells isolated from tumors which developed in irradiated nude mice contained the highest level of intracellular calcium of all the cells examined. These results suggest that an increase in the concentration of intracellular calcium is associated with progression of HPV-18 immortalized keratinocytes to tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654210     DOI: 10.1016/0143-4160(91)90050-o

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  2 in total

1.  Growth and differentiation stimuli induce different and distinct increases in intracellular free calcium in human keratinocytes.

Authors:  G R Sharpe; C Fisher; J I Gillespie; J R Greenwell
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

2.  Dietary Calcium Intake and HPV Infection Status Among American Women: A Secondary Analysis from National Health and Nutrition Examination Survey (NHANES) Data Set of 2003 - 2016.

Authors:  Ai-Juan He; Chi Chen; Min Jia; Rui-Qiang Fan
Journal:  Med Sci Monit       Date:  2020-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.